Astellas Pharma Inc. provided consolidated earnings guidance for the year ending March 31, 2022. For the period, the company expects revenue to be JPY 1,323,000 million, operating profit to be JPY 218,000 million, profit for the year to be JPY 174,000 million and basic earnings per share to be JPY 93.90.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,528 JPY | -0.88% | -1.96% | -9.40% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.40% | 17.57B | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- 4503 Stock
- News Astellas Pharma Inc.
- Astellas Pharma Inc. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2022